Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Adlai Nortye Closes $97.5 Million Nasdaq IPO, Drops 27% Lower in Trading

ImmuneOnco Stages $30 Million Hong Kong IPO for Innate/Adaptive Immunity Drugs

Mirxes Closes $50 Million Round for miRNA Tests; Will IPO in Hong Kong

Kelun-Biotech Raises $174 Million in Hong Kong IPO for ADC Portfolio

Kelun-Biotech Could Raise $208 Million in Hong Kong IPO for ADC Portfolio

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China